Experimental research of host macrophage canceration induced by glioma stem progenitor cells

Molecular Medicine Reports

Volumn 11, Issue 4, 2015, Pages 2435-2442

  Wang, Aidong ^a   Dai, Xingliang ^a   Cui, Baoqian ^a   Fei, Xifeng ^b   Chen, Yanming ^a   Zhang, Jinshi ^a   Zhang, Quanbin ^c   Zhao, Yaodong ^c   Wang, Zhimin ^b   Chen, Hua ^d   Lan, Qing ^a   Dong, Jun ^a   Huang, Qiang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cell canceration; Fluorescent nude mice; Macrophage; Tumor transplantation

Indexed keywords

CHLORDANE; GREEN FLUORESCENT PROTEIN; RED FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; CANCER STEM CELL; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PERITONEAL CAVITY; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; CELL PROLIFERATION; DISEASE COURSE; DISEASE MODEL; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

MUS; MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLIOMA; HETEROGRAFTS; HUMANS; MACROPHAGES; MICE; NEOPLASTIC STEM CELLS; TRANSFECTION; TUMOR BURDEN;

EID: 84921364490     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.3032     Document Type: Article

References (50)

1. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
2. Fukuda K, Kobayashi A and Watabe K: The role of tumor-associated macrophage in tumor progression. Front Biosci (Schol Ed) 4: 787-798, 2012.
3. Galdiero MR, Garlanda C, Jaillon S, Marone G and Mantovani A: Tumor associated macrophages and neutrophils in tumor progression. J Cell Physiol 228: 1404-1412, 2013.
4. Lin EY, Li JF, Gnatovskiy L, et al: Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66: 11238-11246, 2006.
5. Kurahara H, Takao S, Maemura K, et al: M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas 42: 155-159, 2013.
6. Behnes CL, Bremmer F, Hemmerlein B, et al: Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma. Virchows Arch 464 191-196, 2014
7. Shirabe K, Mano Y, Muto J, et al: Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today 42: 1-7, 2012.
8. Obeid E, Nanda R, Fu YX and Olopade OI: The role of tumor-associated macrophages in breast cancer progression (review). Int J Oncol 43: 5-12, 2013.
9. Lee CH, Liu SY, Chou KC, et al: Tumor-associated macrophages promote oral cancer progression through activation of the Axl signaling pathway. Ann Surg Oncol 21: 1031-1037, 2014.
10. Balkwill FR: The chemokine system and cancer. J Pathol 226: 148-157, 2012.
11. Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78, 2004
12. Allavena P, Sica A, Solinas G, Porta C and Mantovani A: The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 66: 1-9, 2008.
13. Solinas G, Germano G, Mantovani A and Allavena P: Tumor - associated macrophages (TAM) as major players of the cancerrelated inflammation. J Leukoc Biol 86: 1065-1073, 2009
14. Pello OM and Andrés V: Role of c-MYC in tumor-associated macrophages and cancer progression. Oncoimmunology 2: e22984, 2013.
15. Charles NA, Holland EC, Gilbertson R, Glass R and Kettenmann H: The brain tumor microenvironment. Glia 59: 1169-1180, 2011.
16. Bouvet M, Tsuji K, Yang M, et al: In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res 66: 11293-11297, 2006.
17. Dong J, Dai XL, Lu ZH, et al: Incubation and application of transgenic green fluorescence nude mice in visualization studies on glioma tissue remodeling. Chin Med J (Engl) 125: 4349-4354, 2012.
18. Wan Y, Fei XF, Wang ZM, et al: Expression of miRNA-125b in the new highly invasive glioma stem cell and progenitor cell line SU3. Chin J Cancer 31: 207-214, 2012.
19. Lu ZH, Lv K, Zhang JS, et al: Establishment of a green fluorescent protein tracing murine model focused on the functions of host components in necrosis repair and the niche of subcutaneously implanted glioma. Oncol Rep 31: 657-664, 2014
20. Seabright M: A rapid banding technique for human chromosomes. Lancet 2: 971-972, 1971.
21. Parodi B, Aresu O, Bini D, et al: Species identification and confirmation of human and animal cell lines: a PCR-based method. Biotechniques 32: 432-434, 436, 438-440, 2002.
22. Raschke WC, Baird S, Ralph P and Nakoinz I: Functional macrophage cell lines transformed by Asbelson leukemia virus. Cell 15: 261-267, 1978.
23. Kerkar SP and Restifo NP: Cellular constituents of immune escape within the tumor microenvironment. Cancer Res 72: 3125-3130, 2012.
24. Shabo I and Svanvik J: Expression of macrophage antigens by tumor cells. Adv Exp Med Biol 714: 141-150, 2011.
25. Mossor DM: The many faces of macrophage activation. J Leukoc Biol 73: 209-212, 2003.
26. Mora R and Regnier-Vigouroux A: Autophagy-driven cell fate decision maker: activated microglia induce specific death of glioma cells by a blockade of basal autophagic flux and secondary apoptosis/necrosis. Autophagy 5: 419-421, 2009.
27. Wu A, Wei J, Kong LY, et al: Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol 12: 1113-1125, 2010.
28. Waldron JS, Yang I, Han S, et al: Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma. J Clin Neurosci 17: 1543-1547, 2010.
29. Goldenberg DM and Pavia RA: Malignant potential of murine stromal cells after transplantation of human tumors into nude mice. Science 212: 65-67, 1981.
30. Sparrow S, Jones M, Billington S and Stace B: The in vivo malignant transformation of mouse fibroblasts in the presence of human tumour xenografts. Br J Cancer 53: 793-797, 1986.
31. Gupta V, Rajaraman S, Gadson P and Costanzi JJ: Primary transfection as a mechanism for transformation of host cells by human tumor cells implanted in nude mice. Cancer Res 47: 5194-5201, 1987.
32. Russell PJ, Brown J, Grimmond S, et al: Tumour-induced host stromal-cell transformation: induction of mouse spindle-cell fibrosarcoma not mediated by gene transfer. Int J Cancer 46: 299-309, 1990.
33. Gupta V, Rajaraman S and Eberle R: Spontaneous induction of malignancy in mouse cells by a human small cell lung cancer implanted in nude mice. Carcinogenesis 11: 713-722, 1990.
34. Bryzgalov I P, Iudicheva TV, GaletskiѤ SA, Solov'ev IuN and Revazova ES: Induction of stromal cell transformation in xenografts of human colonic cancer. Biull Eksp Biol Med 113: 399-402, 1992 (In Russian).
35. Cate CC, Belloni DR and Marin-Padilla M: Acquisition and enhanced expression of the metastatic phenotype following transfections of genomic mouse tumor DNA containing human SCLC gene sequences. Clin Exp Metastasis 13: 203-217, 1995.
36. Ozen M, Multani AS, Kuniyasu H, et al: Specific histologic and cytogenetic evidence for in vivo malignant transformation of murine host cells by three human prostate cancer cell lines. Oncol Res 9: 433-438, 1997.
37. Pathak S, Nemeth MA, Multani AS, et al: Can cancer cells transform normal host cells into malignant cells? Br J Cancer 76: 1134-1138, 1997.
38. Sinkovics JG: Horizontal gene transfers and cell fusions in microbiology, immunology and oncology (Review). Int J Oncol 35: 441-465, 2009.
39. Goldenberg DM, Gold DV, Loo M, et al: Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology. PLoS One 8: e55324, 2013.
40. Goldenberg DM, Zagzag D, Heselmeyer-Haddad KM, et al: Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo. Int J Cancer 131: 49-58, 2012.
41. Goldenberg DM: Horizontal transmission of malignancy by cell-cell fusion. Expert Opin Biol Ther 12: S133-S139, 2012.
42. Rappa G, Mercapide J and Lorico A: Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. Am J Pathol 180: 2504-2515, 2012.
43. Holmgren L, Bergsmedh A and Spetz AL: Horizontal transfer of DNA by the uptake of apoptotic bodies. Vox Sang 83: 305-306, 2002.
44. Yu F, Hsieh WS, Petersson F, et al: Malignant cells derived from 3T3 fibroblast feeder layer in cell culture for nasopharyngeal carcinoma. Exp Cell Res 322: 193-201, 2014.
45. García-Olmo DC, Domínguez C, García-Arranz M, et al: Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res 70: 560-567, 2010.
46. García-Olmo DC, Picazo MG and García-Olmo D: Trans formation of non-tumor host cells during tumor progression: theories and evidence. Expert Opin Biol Ther 12 (Suppl 1): S199-S207, 2012.
47. Durrett R, Foo J, Leder K, Mayberry J and Michor F: Intratumor heterogeneity in evolutionary models of tumor progression. Genetics 188: 461-477, 2011.
48. Lee AJ and Swanton C: Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics. Biochem Pharmacol 83: 1013-1020, 2012.
49. Xu X, Hou Y, Yin X, et al: Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148: 886-895, 2012.
50. Hou Y, Song L, Zhu P, et al: Single-cell exome sequencing and monoclonal evolution of JAK2-negative myeloproliferative neoplasm. Cell 148: 873-885, 2012.